Skip to content
TP
Company

Updated:

Tracon Pharmaceuticals, Inc.

Tracon Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001394319, and its reported...

Overview

Tracon Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001394319, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-05, it reported annual revenue of USD 12,045,000; net income of USD -3,588,000; total assets of USD 10,105,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Tracon Pharmaceuticals, Inc.
Former names in filing history
Tracon Pharmaceuticals Inc (2007-03-22 to 2014-09-15)
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
San Diego, CA, United States
Fiscal year end
December 31
SEC CIK
0001394319

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2023USD$12.0M-$3.6M$10.1M$8.6M$3.7M
FY2022USD$0-$29.1M$19.5M$17.4M-$26.2M
FY2021USD$346,000-$28.7M$26.6M$24.1M-$22.6M
FY2020USD$0-$16.8M$37.4M$32.1M-$17.0M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
DEF 14ADEF 14A
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
S-1—S-1

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Tracon Pharmaceuticals, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Tracon Pharmaceuticals, Inc. | San Diego Company | Altss